New

Global ETF Survey 2026 Available: How 620 Professionals Select ETFs. Access the Report →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

Trackinsight Global ETF Survey 2026
›ETF Issuers›Fidelity›FBIE
FBIE

Fidelity EUR Corp Bond Research Enhanced UCITS ETF

Active ETFFixed IncomeESG
Not rated

The FBIE Exchange Traded Fund (ETF) is provided by Fidelity. This fund is actively managed; it does not track an index. The dividend policy is capitalization.

Advertisement

Advertisement

API
PerformanceJan 29, 2026 - Nov 4, 2026
-2.00%-1.50%-1.00%-0.50%0.00%0.50%FEBAPRJUNAUGOCTFEBAPRJUNAUGOCT
Flows
Join for free to unlock
Data as of 09/30/26
Finance
46.42%
Industrials
10.93%
Healthcare
8.12%
Technology
6.09%
Consumer Non-Cyclicals
4.93%
Utilities
4.70%
Energy
4.53%
Non-Energy Materials
4.30%
Unavailable
2.16%
Other
7.82%
Latest FBIE news

No content available for this fund

FAQ about FBIE

FBIE is an actively managed ETF. This ETF provides exposure to Mixed Ratings Corporate Bonds.
FBIE carries a total expense ratio (TER) of 0.2%.
FBIE was introduced to the market on January 27, 2026.
Fidelity EUR Corp Bond Research Enhanced UCITS ETF, FBIE, is provided by Fidelity. Learn more about Fidelity here.
FBIE oversees €53M in assets as of November 4, 2026.
FBIE follows a capitalizing, meaning it reinvests income within the fund.
As of September 30, 2026, FBIE has significant geographic allocations in USA, France and Germany.
As of September 30, 2026, FBIE focuses largely on Finance, Industrials and Healthcare.
As of September 30, 2026, FBIE holds 143 positions in its portfolio, with 15.71% of assets concentrated in its top 15 holdings.
As of September 30, 2026, FBIE top three holdings include BNP Paribas, 2.88% 6may2030, EUR (20315), SAP SE, 3.5% 3jun2033, EUR and Novo Nordisk, 2.375% 27may2028, EUR.
The base currency of FBIE is EUR.
Data as of 09/30/26
BNP Paribas, 2.88% 6may2030, EUR (20315)
1.12%
SAP SE, 3.5% 3jun2033, EUR
1.11%
Novo Nordisk, 2.375% 27may2028, EUR
1.09%
Freeport-McMoRan, 4.125% 1mar2028, USD
1.04%
Mastercard, 1% 22feb2029, EUR
1.04%
AstraZeneca, 0.375% 3jun2029, EUR (9)
1.04%
Novartis AG, 0.625% 20sep2028, EUR
1.03%
Sandvik, 0.375% 25nov2028, EUR (17)
1.03%
JDE Peets, 1.125% 16jun2033, EUR
1.03%
Visa, 2.25% 15may2028, EUR
1.03%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring
Trackinsight Global ETF Survey 2026: ETFs' Next Act: From Access to Selection. Access the report

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight